Resultados: 16

    Management of opioid use disorder: 2024 update to the national clinical practice guideline

    CMAJ; 196 (38), 2024
    In an evolving landscape of practices and policies, reviewing and incorporating the latest scientific evidence is necessary to ensure optimal clinical management for people with opioid use disorder. We provide a synopsis of the 2024 update of the 2018 National Guideline for the Clinical Management of Opi...

    Guideline No. 452: diagnosis and management of intrahepatic cholestasis of pregnancy

    J. obstet. gynaecol. Can; 46 (8), 2024
    To summarize the current evidence and to make recommendations for the diagnosis and management of intrahepatic cholestasis of pregnancy. Pregnant people with intrahepatic cholestasis of pregnancy. Diagnosing the condition using fasting or non-fasting bile acids, classifying disease severity, determining ...

    Open Access Pan American League of Associations for Rheumatology recommendations for the treatment of psoriatic arthritis

    J. rheumatol; 51 (5), 2024
    Psoriatic arthritis (PsA) is chronic disease that compromises multiple domains and might be associated with progressive joint damage, increased mortality, functional limitation, and considerably impaired quality of life. Our objective was to generate evidence-based recommendations on the management of Ps...

    Guideline No. 445: management of chronic pelvic pain

    J. obstet. gynaecol. Can; 46 (1), 2024
    To provide evidence-based recommendations for the management of chronic pelvic pain in females. This guideline is specific to pelvic pain in adolescent and adult females and excluded literature that looked at pelvic pain in males. It also did not address genital pain. The intent is to benefit patients wi...

    Guideline No 428: management of dichorionic twin pregnancies

    J. obstet. gynaecol. Can; 44 (7), 2022
    To review evidence-based recommendations for the management of dichorionic twin pregnancies. Pregnant women with a dichorionic twin pregnancy. Implementation of the recommendations in this guideline may improve the management of twin pregnancies and reduce neonatal and maternal morbidity and mortality. P...

    Guideline No. 426: Hypertensive disorders of pregnancy: diagnosis, prediction, prevention, and management

    J. obstet. gynaecol. Can; 44 (5), 2022
    This guideline was developed by maternity care providers from obstetrics and internal medicine. It reviews the diagnosis, evaluation, and management of the hypertensive disorders of pregnancy (HDPs), the prediction and prevention of preeclampsia, and the postpartum care of women with a previous HDP. Impl...

    Guideline No. 414: management of pregnancy of unknown location and tubal and nontubal ectopic pregnancies

    J. obstet. gynaecol. Can; 43 (5), 2021
    To provide an evidence-based algorithm to guide the diagnosis and management of pregnancy of unknown location and tubal and nontubal ectopic pregnancy. All patients of reproductive age. The implementation of this guideline aims to benefit patients with positive β-human chorionic gonadotropin results and...

    Guideline No. 420: cytomegalovirus Infection in Pregnancy

    J. obstet. gynaecol. Can; 43 (7), 2021
    To provide an update on current recommendations for cytomegalovirus (CMV) infection during pregnancy. The objectives of this guideline are: To improve perinatal care providers’ awareness of the consequences of maternal CMV infection for the fetus and the infant; To emphasize the importance of educating...

    Guideline No. 408: management of gestational trophoblastic diseases

    J. obstet. gynaecol. Can; 43 (1), 2021
    This guideline reviews the clinical evaluation and management of gestational trophoblastic diseases, including surgical and medical management of benign, premalignant, and malignant entities. The objective of this guideline is to assist health care providers in promptly diagnosing gestational trophoblast...

    Guideline No. 409: intrauterine fetal diagnostic testing in women with chronic viral infections

    J. obstet. gynaecol. Can; 42 (12), 2020
    This revised guideline provides updated information for the care of women with chronic viral infections who require intrauterine fetal diagnostic testing. Women with chronic viral infections who are pregnant or planning a pregnancy. Non-invasive screening tests for diagnosis: maternal serum placental ana...